Clever Culture Systems (ASX:CC5) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 26, 2026)


What is Clever Culture Systems Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Clever Culture Systems's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

ASX:CC5 vs MSFT, ORCL, PLTR: Margin of Safety % (DCF Earnings Based) Comparison

For the Software - Infrastructure subindustry, Clever Culture Systems's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clever Culture Systems Margin of Safety % (DCF Earnings Based) vs Software Industry

For the Software industry and Technology sector, Clever Culture Systems's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Clever Culture Systems's Margin of Safety % (DCF Earnings Based) falls into.


Clever Culture Systems Business Description

Address 16 Anster Street, Adelaide, SA, AUS, 5000
Clever Culture Systems Ltd provides intelligent automation solutions to microbiology laboratories. The Company has developed a technology, the Automated Plate Assessment System (APAS Independence), using artificial intelligence and machine learning software to automate the imaging, analysis, and interpretation of microbiology culture plates. The technology remains the only U.S. FDA-cleared artificial intelligence technology for automated culture plate reading. The Group operates in one business segment, researching, developing, and commercialising innovative technologies. Its geographic areas are Australia, the UK, Sweden, the Netherlands, and Others. It generates the majority revenue from the Australia region.